Published: August 13, 2021 Read the Full Publication >> Background: Lung cancer is the leading cause of cancer-related death in the United States and globally, andmany questions exist about treatment options. Harmonizing data across registries and other data collection efforts would yield a robust data infrastructure to help address many research questions. The purpose of[…]
AdvaMed Publish Date: November 3, 2022 Read the Full Article>> Challenges of AI in MedTech In the medical device space, powerful insights from real-world data can seem ‘just out of reach’. Capturing patient characteristics and outcomes, at scale and with consistency over time, is challenging outside of clinical trials. Personalization – bridging the gap between[…]
HealthEconomics.com – A Scientist.com Company Publish Date: August 26th, 2022 Multiple sclerosis (MS) is a chronic illness in which the body’s immune system attacks myelin, the substance that surrounds and protects the nerve fibers of the central nervous system. The result is a disabling disease that causes damage to the brain and spinal cord[…]
Gastrointestinal and metabolic disorders are highly prevalent and result in reduced quality of life for many patients. Treatments are aimed at reducing symptoms and preventing complications and progression. More research is needed to better understand natural history and progression, treatment effectiveness, and outcomes. Register here Linked real-world data (RWD) and machine learning (ML) applications provide[…]
THU, JUN 9, 2022 11:00 AM – 12:00 PM EDT Register >> Assessing clinical and functional status in Multiple Sclerosis (MS) using the Expanded Disability Status Scale (EDSS) is critical to inform treatment decisions and monitoring the progression of illness. Yet, EDSS scores are documented infrequently and inconsistently due to the time required to complete[…]
